Verismo Therapeutics logo

Verismo Therapeutics

Philadelphia, PA

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells without triggering the T-cell exhaustion for the treatment of solid tumors. The lead therapy candidates in preclinical development are targeting pancreatic cancer, mesothelioma, and ovarian cancer.

verismotherapeutics.com

Company Details

Founded

2020

Employees

Between 5 - 20 employees

Raised

$40,000,000

Headquarters Location

Philadelphia, PA

Public

No

Acquired

No

CEO

Bryan KimBryan Kim

Founders

Michael Milone
Michael Milone
Donald Siegel
Donald Siegel
Bryan Kim
Bryan Kim

Company Collections

These are collections Verismo Therapeutics is a part of. Click on the collection name to view similar companies.

Verismo Therapeutics' Tech Stack